Get the Stockscreener App
87.07
1.22%
1.05
After Hours:
87.51
0.44
+0.51%
Zimmer Biomet Holdings Inc stock is traded at $87.07, with a volume of 1.83M.
It is up +1.22% in the last 24 hours and down -4.10% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$86.02
Open:
$86.3
24h Volume:
1.83M
Relative Volume:
0.83
Market Cap:
$17.26B
Revenue:
$8.01B
Net Income/Loss:
$807.20M
P/E Ratio:
21.55
EPS:
4.0411
Net Cash Flow:
$1.13B
1W Performance:
+0.54%
1M Performance:
-4.10%
6M Performance:
-6.70%
1Y Performance:
-21.29%
1-Day Range:
$85.13
$87.10
1-Week Range:
$84.59
$88.06
52-Week Range:
$84.59
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
87.07 | 17.05B | 8.01B | 807.20M | 1.13B | 4.0411 |
|
ABT
Abbott Laboratories
|
109.30 | 184.48B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
369.56 | 135.49B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
93.53 | 136.93B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
102.96 | 129.48B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
81.36 | 47.29B | 5.88B | 1.34B | 799.60M | 2.3489 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Zimmer Biomet Stock Just Flashed A Major Signal: Smart Money Is Moving – Are You? - AD HOC NEWS
CHF67.50 intraday drop: ZBH.SW Zimmer Biomet (SIX) oversold bounce setup 30 Jan 2026 - Meyka
Y Intercept Hong Kong Ltd Decreases Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (NYSE:ZBH) Sets New 52-Week LowHere's What Happened - MarketBeat
Expert Outlook: Zimmer Biomet Holdings Through The Eyes Of 13 Analysts - Benzinga
Zimmer Biomet stock hits 52-week low at $85.15 By Investing.com - Investing.com Australia
Zimmer Biomet stock hits 52-week low at $85.15 - Investing.com
Market Leaders: What is the dividend yield of Zimmer Biomet Holdings IncTrade Entry Report & Smart Investment Allocation Insights - baoquankhu1.vn
ZBH.SW Zimmer Biomet (SIX) spikes to CHF67.50 pre-market 28 Jan 2026: monitor liquidity - Meyka
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution - PR Newswire
TD Cowen assumes coverage on Zimmer Biomet stock with Buy rating - Investing.com Nigeria
TD Cowen assumes coverage on Zimmer Biomet stock with Buy rating By Investing.com - Investing.com South Africa
Global Arthroscopy Devices Market is Expected to Expand at a Healthy Growth Rate of ~5% by 2032 | DelveInsight - GlobeNewswire Inc.
What Analysts Think Is Reframing Zimmer Biomet (ZBH) Story For Investors - Yahoo Finance
Zimmer Biomet Holdings (ZBH)’s 2026 expectations remain cautious amid internal reset - MSN
3 New 5-Star Stocks This Week - Morningstar
Decliners Report: Is Zimmer Biomet Holdings Inc exposed to currency risksJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - baoquankhu1.vn
Support Test: Is FBNC stock overvalued or fairly priced2025 Year in Review & Smart Investment Allocation Insights - baoquankhu1.vn
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by Sector Gamma AS - MarketBeat
Strs Ohio Cuts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
ARGA Investment Management LP Acquires Shares of 154,539 Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
How Investors May Respond To Zimmer Biomet (ZBH) Cautious 2026 Outlook And Executive Departure - simplywall.st
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) - GlobeNewswire
Report: Zimmer Biomet planning layoffs - Inside INdiana Business
The Truth About Zimmer Biomet Stock: Silent Boom Or Boring Boomer Play? - AD HOC NEWS
Layoffs underway at Warsaw-based Zimmer Biomet - wsbt.com
Zimmer Biomet launches new foot and ankle system - MassDevice
Bone Growth Stimulator Market Covering Prime Factors - openPR.com
Rakuten Investment Management Inc. Makes New $37.31 Million Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (ZBH)’s 2026 Expectations Remain Cautious Amid Internal Reset - Insider Monkey
Q3 Rundown: Zimmer Biomet (NYSE:ZBH) Vs Other Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
Income Plays: Is CAPS currently under institutional pressureEarnings Risk Summary & Weekly High Potential Alerts - baoquankhu1.vn
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions - Intellectia AI
Short Interest in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Rises By 33.0% - MarketBeat
Is It Time To Reassess Zimmer Biomet (ZBH) After Prolonged Share Price Weakness - Yahoo Finance
Zimmer Biomet (ZBH) Valuation Check After Cautious Guidance At J.P. Morgan Healthcare Conference - Sahm
Minneapolis Portfolio Management Group LLC Has $26.02 Million Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet granted CE Mark for RibFix Advantage Fixation System - MSN
Zimmer Biomet (NYSE:ZBH) Upgraded to Buy at Wall Street Zen - MarketBeat
Zimmer Biomet (ZBH) Mixes Executive Exit With Big DTC Push Is Management Rewriting Its Playbook? - simplywall.st
Goldman Sachs Adjusts Price Target on Zimmer Biomet to $88 From $93, Maintains Sell Rating - marketscreener.com
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results - BioSpace
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock - sharewise.com
What is the dividend yield of Zimmer Biomet Holdings IncQuarterly Trade Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Buyback Watch: What is the dividend yield of Zimmer Biomet Holdings Inc2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Zimmer Biomet’s Q3 2025 earnings: What to expect - MSN
Zimmer Biomet Announces Webcast and Conference Call of Fourth Qu - GuruFocus
Zimmer Biomet Announces Q4 2026 Earnings Call Date - Intellectia AI
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)? - Yahoo Finance
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):